ClinicalTrials.gov
ClinicalTrials.gov Menu

GSK1120212+GSK2141795 for Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01958112
Recruitment Status : Terminated (Drug supply)
First Posted : October 8, 2013
Last Update Posted : August 21, 2017
Sponsor:
Collaborators:
Novartis
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Ursula A. Matulonis, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : March 2020